People | July 31, 2025
Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
Bayer expects 2025 to be the most difficult year of its turnaround
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Peter Bains has over three decades of experience in the biotech and pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
